Biomarkers and Cardiac CT

Recruiting Observational Study
Coronary Artery Disease Atherosclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
Maastricht University Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in developed countries. In addition, many patients suffer from valvular and aortic disease. Although various tools are available to identify patients with cardiovascular (CV) disease at risk for major adverse cardiac events (MACE), the identification of these patients remains a clinical challenge. One promising avenue i…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients referred from the Cardiology clinic for routine CCTA. Exclusion Criteria: * Pregnancy * Severe renal insufficiency * Severe allergy to contrast medium * Inability to obtain informed consent * Age below 18 years
Contacts

Bas Kietselaer, MD, PhD

+31433871587

b.kietsealer@mumc.nl

CONTACT

Sibel Altintas, MD

+31433881232

s.altintas@mumc.nl

CONTACT